Posters

Post-operative YAG capsulotomy rates with two trifocal intraocular lenses: review of evidence

Poster Details

First Author: Y.Liu CHINA

Co Author(s):    M. Dhariwal                    

Abstract Details

Purpose:

To conduct a review of available evidence on post-operative YAG capsulotomy rates with two trifocal intra-ocular lenses.

Setting:

ESCRS Congress Database review.

Methods:

European Society of Cataract & Refractive Surgeons (ESCRS) congress database was queried using trifocal IOL specific search terms to identify relevant presentations (e-posters, videos and webcasts) from 2015-2019, reporting on post-operative YAG capsulotomy rates of two leading trifocal IOLs (PanOptix, and AT LISA).

Results:

Three comparative studies reported Nd:YAG rates for PanOptix vs. AT LISA. A matched cohort study from Czech Republic reported Nd:YAG rates of 19.6% for AT LISA-tri (19.27 months) and 3.5% for PanOptix (26.5 months). A matched prospective comparative study from Czech Republic reported Nd:YAG rates of 6% for AT LISA-tri and 0.5% for PanOptix at 6 months. A matched prospective-cohort study from The Netherlands reported Nd:YAG rates of 10.7% for AT LISA-tri and 14.3% for PanOptix at 12 months (P=0.11). Other non-comparative studies reported lower Nd:YAG rates with PanOptix (studies duration, 3-9 months) vs. AT LISA-tri (studies duration, 3-24 months).

Conclusions:

Published evidence indicates surgeons can experience favorable YAG capsulotomy outcomes with PanOptix trifocal IOLs compared to AT LISA trifocal IOLs, both at short and long-term post-operative follow-up periods.

Financial Disclosure:

is employed by a for-profit company with an interest in the subject of the presentation, receives consulting fees, retainer, or contract payments from a competing company